Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation.

Acyclovir kinetics after intravenous infusion.

Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation.

Serum antibody levels as risk factors in the dissemination of herpes zoster.

Plasma levels and urinary excretion of vidarabine after repeated dosing.

Cytomegalovirus infection in patients with renal transplants: potentiation by antithymocyte globulin and an incompatible graft.

Herpes simplex encephalitis: need for accurate diagnosis.

The natural history of herpes simplex virus infection of mother and newborn.

Vidarabine therapy of neonatal herpes simplex virus infection.

Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans.